Authors: BEUTELS M VANDAMME P AELVOET W DESMYTER J DONDEYNE F GOILAV C MAK R MUYLLE L PIERARD D STROOBANT A VANLOOCK F WAUMANS P VRANCKX R

Citation: M. Beutels et al., PREVALENCE OF HEPATITIS-A, HEPATITIS-B AND HEPATITIS-C IN THE FLEMISHPOPULATION, European journal of epidemiology, 13(3), 1997, pp. 275-280

Authors: GOILAV C ZUCKERMAN J LAFRENZ M VIDOR E BRIANTAIS P LAUWERS S RATHEAU C BENICHOU G ZUCKERMAN A

Citation: C. Goilav et al., PERSISTENCE OF ANTIBODIES AFTER INACTIVATED HEPATITIS-A VACCINES IN ACOMPARATIVE-STUDY, The Journal of infection, 34(2), 1997, pp. 158-158

Authors: VINGERHOETS J GOILAV C VANHAM G KESTENS L MUYLLE L KEGELS E VANHOOF J PIOT P GIGASE P

Citation: J. Vingerhoets et al., NONRESPONSE TO A RECOMBINANT PRE-S-2-CONTAINING HEPATITIS-B VACCINE -ASSOCIATION WITH THE HLA-SYSTEM, Annales de la Societe belge de medecine tropicale, 75(2), 1995, pp. 125-129

Authors: GOILAV C ZUCKERMAN J LAFRENZ M VIDOR E LAUWERS S RATHEAU C BENICHOU G ZUCKERMAN A

Citation: C. Goilav et al., IMMUNOGENICITY AND SAFETY OF A NEW INACTIVATED HEPATITIS-A VACCINE INA COMPARATIVE-STUDY, Journal of medical virology, 46(3), 1995, pp. 287-292

Authors: VANHAM GL KESTENS L VANHOOF J PENNE G COLEBUNDERS R GOILAV C VANDENBRUAENE M ELHABIB R GIGASE P

Citation: Gl. Vanham et al., IMMUNOLOGICAL PARAMETERS DURING TREATMENT WITH DITIOCARB (IMUTHIOL(R)), AIDS, 7(4), 1993, pp. 525-530